Boonen, Steven; Reginster, Jean-Yves; Kaufman, Jean-Marc; Lippuner, Kurt; Zanchetta, Jose; Langdahl, Bente; Rizzoli, Rene; Lipschitz, Stanley; Dimai, Hans Peter; Witvrouw, Richard; Eriksen, Erik; Brixen, Kim; Russo, Luis; Claessens, Frank; Papanastasiou, Philemon; Antunez, Oscar; Su, Guoqin; Bucci-Rechtweg, Christina; Hruska, Josef; Incera, Elodie; ... (2012). Fracture risk and zoledronic acid therapy in men with osteoporosis. New England journal of medicine NEJM, 367(18), pp. 1714-23. Waltham, Mass.: Massachusetts Medical Society MMS 10.1056/NEJMoa1204061
|
Text
nejmoa1204061.pdf - Published Version Available under License Publisher holds Copyright. Download (663kB) | Preview |
Fractures in men are a major health issue, and data on the antifracture efficacy of therapies for osteoporosis in men are limited. We studied the effect of zoledronic acid on fracture risk among men with osteoporosis.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Orthopaedic, Plastic and Hand Surgery (DOPH) > Clinic of Osteoporosis |
UniBE Contributor: |
Lippuner, Kurt |
ISSN: |
0028-4793 |
Publisher: |
Massachusetts Medical Society MMS |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:35 |
Last Modified: |
05 Dec 2022 14:11 |
Publisher DOI: |
10.1056/NEJMoa1204061 |
PubMed ID: |
23113482 |
Web of Science ID: |
000310440800008 |
BORIS DOI: |
10.7892/boris.14202 |
URI: |
https://boris.unibe.ch/id/eprint/14202 (FactScience: 221057) |
Actions (login required)
 |
Edit item |